알림

Pluri Inc. (PLUR)

NasdaqCM: PLUR · 실시간 가격 · USD

1.60

+0.00 (0.00%)

종가 기준: Aug 17, 2026, 3:52 PM

1.67

+4.37%

프리마켓: 4:57 AM

0.00% (1D)

매수호가	1.66
시가총액	17.26M
매출 (ttm)	1.08M
순이익 (ttm)	-25.54M
베타	0.68
EPS (ttm)	-2.9
P/E (ttm)	n/a
선행 P/E	-0.84
P/B (ttm)	-0.90
P/S (ttm)	16.00
Earnings Date	n/a

매도호가	1.8
거래량	48,570
평균 거래량 (20일)	26,513
시가	1.63
전일 종가	1.60
일중 범위	1.55 - 1.67
52주 범위	1.45 - 5.68
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

PLUR 소개

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. Its product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal ce...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Jun 30, 2003

직원 수 127

상장 거래소 NasdaqCM

티커 PLUR

웹사이트 https://www.pluri-biotech.com

전체 기업 정보

재무 실적

2025년 Pluri의 매출은 1.34M로, 전년 326K 대비 309.82% 증가했습니다. 순이익은 -22.58M로, 8.11% 증가했습니다.

재무제표

어닝 서프라이즈

Pluri가 Nov 12, 2025에 분기 실적을 발표했습니다:

매출 $167K 예상치 하회 $0, 및 -60.89% 전년 대비 감소.

EPS -0.65 예상치 상회 0.09, 및 70.98% 전년 대비 성장.

뉴스

2개월 전 · Insider Monkey

Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In

We just covered the 7 Best Lab-Grown Meat Stocks to Invest In and Pluri Inc. (NASDAQ:PLUR) ranks 4th on this list. Pluri Inc. (NASDAQ:PLUR), through the highly publicized joint venture, Ever After Foo...

2개월 전 · Simply Wall St.

Pluri Insider Ups Holding During Year

Insiders were net buyers of Pluri Inc.'s ( NASDAQ:PLUR ) stock during the past year. That is, insiders bought more...

3개월 전 · Benzinga

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug

NewcelX Ltd. reported its 2025 financial results, with leadership emphasizing a "transformative year" marked by merger completion, balance sheet improvements, and progress in its lead Type 1 diabetes ...

6개월 전 · Associated Press Finance

Pluri: Fiscal Q2 Earnings Snapshot

HAIFA, Israel (AP) — Pluri Inc. PLUR) on Thursday reported a loss of $6.5 million in its fiscal second quarter. The Haifa, Israel-based company said it had a loss of 71 cents per share.

6개월 전 · Proactive

Pluri showcases cell expansion platform as Resbiomed program advances

Pluri Inc CEO Yaky Yanay joined Steve Darling from Proactive to provide deeper insight into the company’s proprietary cell expansion technology and its strategic growth across both therapeutics and fo...

2 페이지 중 1